PHIO - Phio Pharmaceuticals Corp.
IEX Last Trade
1.885
-0.005 -0.265%
Share volume: 20
Last Updated: Fri 27 Dec 2024 04:26:13 PM CET
Research and Development in Biotechnology (except Nanobiotechnology):
0.12%
PREVIOUS CLOSE
CHG
CHG%
$1.89
0.00
-0.26%
Summary score
26%
Profitability
25%
Dept financing
6%
Liquidity
50%
Performance
25%
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Long-term ratios 30-Jun-2016 - 30-Jun-2020
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-68.53%
Return on assets
-29.42%
Return on sales
0%
Return on invested capital
152.84%
Total debt ratio
32.2%
Debt ratio change over timeo
-0.73%
Current Ratio
4.58%
Quick Ratio
0%
Cash Position Ratio
4.53%
Short-term ratios 30-Jun-2019 - 30-Jun-2020
The data are presented for the financials results of the quarters of the last year.
Return on equity
-25.71%
Return on assets
-19.72%
Return on sales
0%
Return on invested capital
181.68%
Total debt ratio
20.38%
Debt ratio change over timeo
-0.89%
Current Ratio
6.45%
Quick Ratio
0%
Cash Position Ratio
6.22%
Last quarter ratios 30-Jun-2020
The data are presented for the financials results of the last quarter.
Return on equity
-9.43%
Return on assets
-8.26%
Return on sales
0%
Return on invested capital
135.28%
Total debt ratio
12.26%
Debt ratio change over time
-0.94%
Current Ratio
10.33%
Quick Ratio
0%
Cash Position Ratio
9.99%
Performance ratios (change over 4 years) 30-Jun-2016 - 30-Jun-2020
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-160.73%
Return on assets
-123.5%
Return on sales
0%
Return on invested capital
9.3%
Total debt ratio
-72.93%
Debt ratio change over time
-0.73%
Current Ratio
2.39%
Quick Ratio
0%
Cash Position Ratio
2.38%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | PHIO | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -68.53% | -3.05% | 11.55% | 6.27% |
| Return on assets | -29.42% | 3.6% | 3.57% | 5.27% |
| Return on sales | 0% | 32.14% | 42.16% | 33.08% |
| Return on invested capital | 152.84% | 5.09% | 7.99% | 13.19% |
| Profitability | 25% | 37% | 68% | 60% |
| Total debt ratio | 32.2% | 101.18% | 74.11% | 29.58% |
| Debt ratio change over time | -0.73% | 6.09% | 6.03% | 1.53% |
| Dept financing | 8% | 50% | 43% | 14% |
| Current Ratio | 6.45% | 2.08% | 2.02% | 3.51% |
| Quick Ratio | 0% | 1.96% | 1.71% | 2.86% |
| Cash Position Ratio | 6.22% | 1.48% | 0.76% | 1.49% |
| Liquididy | 50% | 22% | 48% | 50% |
| Short-term ratios | PHIO | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -25.71% | -25.62% | 17.94% | 7.14% |
| Return on assets | -19.72% | 3.26% | 3.67% | 4.71% |
| Return on sales | 0% | 31.22% | 37.5% | 33.58% |
| Return on invested capital | 181.68% | 8.14% | 7.17% | 18.16% |
| Profitability | 25% | 39% | 70% | 60% |
| Total debt ratio | 20.38% | 105.33% | 83.42% | 27.49% |
| Debt ratio change over time | -0.89% | -23.44% | 9.66% | 0.6% |
| Dept financing | 5% | 25% | 45% | 8% |
| Current Ratio | 6.45% | 2.08% | 2.02% | 3.51% |
| Quick Ratio | 0% | 1.96% | 1.71% | 2.86% |
| Cash Position Ratio | 6.22% | 1.48% | 0.76% | 1.49% |
| Liquididy | 50% | 31% | 26% | 45% |